Orbimed Advisors
$4.6B 13F equity value
126 Holdings
Latest filing 2026-03-31
Top Holdings
| Ticker | Company | Shares | Value | Weight |
|---|---|---|---|---|
| EWTX | EDGEWISE THERAPEUTICS INC | 15,518,492 | $489M | 10.7% |
| ELVN | ENLIVEN THERAPEUTICS INC | 7,959,538 | $312M | 6.8% |
| LLY | ELI LILLY & CO | 236,800 | $218M | 4.8% |
| SVA | SINOVAC BIOTECH LTD | 2,718,735 | $184M | 4.0% |
| BSX | BOSTON SCIENTIFIC CORP | 2,382,100 | $149M | 3.3% |
| SION | SIONNA THERAPEUTICS INC | 3,530,702 | $142M | 3.1% |
| AZN | ASTRAZENECA PLC | 670,200 | $132M | 2.9% |
| MYGN | MYRIAD GENETICS INC | 125,000,000 | $123M | 2.7% |
| MBX | MBX BIOSCIENCES INC | 3,637,887 | $109M | 2.4% |
| CRVS | CORVUS PHARMACEUTICALS INC | 7,165,006 | $105M | 2.3% |
Track Orbimed Advisors's 13F portfolio: $4.6B in reported holdings, 126 positions. Top holdings and quarterly changes on SentiSense.